| N/A | Liver cancer research - From bench to translational applications | 1032000 | 2013 | | |
| N/A | NANOG and chemoresistance of ovarian cancer-initiating cells | 1056000 | 2014 | | |
| N/A | Characterization of a Novel Splice Variant in Tamoxifen Resistant Breast Cancer | 1116180 | 2015 | | |
| N/A | Novel Microbe Discovery and Microbial Genomics | 1116180 | 2015 | | |
| N/A | Virology and pathogenesis of avian influenza and SARS | 309382 | 2005 | | |
| N/A | A study of molecular mechanisms and characterizing novel genes in liver cancer | 670720 | 2005 | | |
| N/A | Genomics, genetics and clinico-pathological study of gastrointestinal cancers | 779642 | 2007 | | |
| N/A | Investigations into influenza receptor binding and novel therapies in an ex-vivo setting | 780475 | 2009 | | |
| N/A | Discovery and characterization of novel microbes with epidemic potential | 545917 | 2006 | | |
| N/A | Croucher Foundation Senior Medical Research Fellowships | 739900 | 1998 | | Principal Investigator (PI) | | |
|
| N/A | Prophylaxis and treatment of recurrent hepatitis B after liver transplantation | 767650 | 2004 | | |
| N/A | Developing an anti-inflammatory platform to combat chronic kidney disease | 4426100 | 2018 | | Principal Investigator (PI) | | |
|
| N/A | Roles of regulatory T cells and fibronectin in chronic hepatitis B disease with HBsAg seroclearance | 4541360 | 2020 | | Principal Investigator (PI) | | |
|
| N/A | Develop a high throughput platform for personalized treatment of acute myeloid leukaemia | 2746040 | 2017 | | Principal Investigator (PI) | | |
|
